Dams are headed for the climate, health triumphs after ups and downs

Washington — It has been over a year in the making and has seen a lot of ups and downs. Now, a democratic economic package focused on climate and Health Care faces obstacles, but seems poised for a Congress party-line passage next month.

The approval will let President Joe Biden and his party claim victory over top priorities as November’s election approaches. They haven’t forgotten that they came close to approving a much larger version of the bill last year, only to see Sen. Joe Manchin, DW.VA, one of their most conservative and contradictory members, torpedo it at the eleventh hour. .

This time, Senate Majority Leader Chuck Schumer, D.N.Y., to everyone’s surprise, has worked out a settlement package with Manchin that has made the West Virginian partner from Paria. The measure is more modest than earlier versions, but still checks the boxes on issues that pique Democrats.

Here’s what they face:

what does it have?

The measure would raise $739 billion in revenue over 10 years and cost $433 billion. More than $300 billion will be left to reduce the federal deficit.

They are meaningful cuts in red ink. But they are small compared to the $16 trillion in new debt the nonpartisan Congressional Budget Office estimates will accumulate over the next decade.

The package will save consumers and government money by curbing drug prices, and it will subsidize private Health Insurance for millions. This would strengthen the IRS budget so that the tax agency could collect more unpaid taxes.

The plan would promote clean energy and offshore energy drilling, a balancing act sought by Manchin, the champion of fossil fuels. It will also collect new taxes from the largest corporations and wealthy hedge fund owners.

It’s part of a $3.5 trillion package that Biden proposed at the start of his presidency, which also envisioned sums for initiatives like paid family leave and universal preschool. That’s even smaller than the nearly $2 trillion option passed last November, when Manchin called for a cut, still citing inflation fears that derailed the deal.


This is now called the “Inflation Reduction Act”, but…

… will he? It certainly can be, but there are dissatisfaction.

First, some context.

Prices rose 6.8% in June from a year earlier, the biggest increase in four decades, according to an inflation measure by the Federal Reserve. Then government data shows the economy shrank in the last quarter, raising concerns about a recession.

“Improved tax collections, drug savings and deficit reduction will put pressure on inflation,” a responsible federal budget committee said on Friday. For a review that passes, the bipartisan fiscal watchdog group called the legislation “exactly the kind of package lawmakers should put in place to help the economy in many ways.”

“The deficit reduction is almost always inflation-reducing,” a Harvard University economics professor who was President Barack Obama’s top economic adviser wrote Friday in the Wall Street Journal. He said the measure would “reduce inflation by slowing the rise in prescription-drug prices.”

A more serious assessment came from the University of Pennsylvania’s Penn Wharton budget model, which analyzes economic issues.

“The act will slightly increase inflation until 2024 and then reduce inflation thereafter,” the group wrote on Friday. “These point estimates are statistically indistinguishable from zero, indicating low confidence that the law will have any effect on inflation.”

A group of Republicans say the Democrats’ bill would be widely damaging. Senate Minority Leader Mitch McConnell, R-Ky., called it “a massive package of new job-killing tax increases, Green New Deal madness that will kill American energy, and prescription drug socialism that will leave us with fewer new life-savings.” “It’s called medicine.”


further change

The 725-page measurement will probably still change somewhat.

Schumer said last week that Democrats plan to add language aimed at lowering patients’ costs of insulin, a diabetes drug that can cost hundreds of dollars monthly.

Insulin price curbs were the highlight of Democrats’ big package last year, which included a $35 monthly cap for patients receiving the drug through Medicare or private insurers. But this year it decreased as the measure was trimmed.

sense. Jean Shaheen, D.N.H., and Susan Collins, R-Main draft a bill limiting the price of insulin. The prospects for that measure fell short after the non-partisan Congressional Budget Office estimate would cost about $23 billion and actually increase the price of insulin. Both lawmakers haven’t even made up the 10 Republicans who would need to succeed in the 50-50 Senate, where most bills require 60 votes.

It’s unclear what the Democrats’ new insulin language will do. Earlier language that required private insurers to set a $35 monthly insulin cap may violate chamber rules, which only allow provisions that primarily affect the federal budget.

In addition, under the process Democrats are using to move the measure through the chamber by a simple majority, with Vice President Kamala Harris’s tiebreaking vote, it would face several amendments in a voting session that would go on into the night. There is no one else to tell if something will pass.



Every Republican seems ready to vote “no”.

Democrats will need all 50 of their votes in the Senate, where unlikely Sen. Kirsten Cinemas, D-Ariz., has yet to state her view.

Democrats can lose no more than four House votes to succeed there. Speaker Nancy Pelosi, D-Calif., said Friday that when the Senate approves the package, “we will pass it.”

Schumer wants to pass the Senate next week. He acknowledged that the timeline is “going to be tough” because the chamber’s lawmaker will take time to ensure the bill is in line with Senate rules.

This too will take luck. All 50 Democrats, including both independents who support him, would have to be healthy enough to show up and vote.

It is not guaranteed. The latest, highly contagious COVID-19 variant is spreading across the country. And the chamber has 33 senators who are 70 years of age or older, including 19 Democrats.

Sen. Richard Durbin, D-Ill., 77, was the latest senator to announce he had contracted the disease. Patrick Leahy, D-VT, 82, has passed out after hip surgery. Both are expected to be back next week.

Be the first to comment

Leave a Reply

Your email address will not be published.